nChroma Bio
PrivateLast Round
Series I
12/11/2024
Total Funding Raised
$435M
Company Overview
nChroma Bio is a biotechnology company developing in vivo targeted genetic medicines to treat a wide array of diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
nChroma Bio Comps
Public and private peers based on sector, stage, and business model.
nChroma Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series I | 12/11/2024 | ||||
| Series B | 3/1/2023 | ||||
| Series A | 11/17/2021 |
Key People
Founding team and executive leadership
nChroma Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Seed, Series B, Series A, Series I |
| Janus Henderson Group | Series I, Series B, Series A |
| Omega Funds | Series I, Series B, Series A |
| GV | Series I, Seed, Series B |
| DCVC Bio | Series I, Series B |
| F-Prime Capital | Series I, Seed |
| Osage University Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
CRMA-1001 is an epigenetic silencer for chronic hepatitis B.
nChroma Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about nChroma Bio's valuation, stock price, and market status.
